Hari Shyam Selected Research

Centchroman

12/2019	Genistein potentiates Centchroman induced antineoplasticity in breast cancer via PI3K/Akt deactivation and ROS dependent induction of apoptosis.
2/2018	Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells.
4/2017	Centchroman induces redox-dependent apoptosis and cell-cycle arrest in human endometrial cancer cells.
11/2016	Genistein synergizes centchroman action in human breast cancer cells.
1/2012	Polyphenols sensitization potentiates susceptibility of MCF-7 and MDA MB-231 cells to Centchroman.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hari Shyam Research Topics

Disease

7	Neoplasms (Cancer) 12/2021 - 01/2012
6	Breast Neoplasms (Breast Cancer) 12/2019 - 01/2012
2	Chronic Periodontitis 12/2020 - 01/2018
1	COVID-19 07/2022
1	Acute Kidney Injury (Acute Renal Failure) 07/2022
1	Non-Muscle Invasive Bladder Neoplasms 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Bronchiectasis 12/2020
1	Lymphadenopathy 08/2020
1	Squamous Cell Carcinoma of Head and Neck 08/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2018
1	Disease Progression 07/2018
1	Carcinogenesis 01/2018
1	Infections 01/2018
1	Endometrial Neoplasms (Endometrial Cancer) 04/2017
1	Wounds and Injuries (Trauma) 07/2012

Drug/Important Bio-Agent (IBA)

5	CentchromanIBA 12/2019 - 01/2012
3	IsoflavonesIBA 12/2019 - 11/2016
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 08/2020
2	GenisteinIBA 12/2019 - 11/2016
2	Oral ContraceptivesIBA 02/2018 - 11/2016
2	ormeloxifeneIBA 04/2017 - 11/2016
2	CurcuminIBA 07/2012 - 01/2012
1	Biological ProductsIBA 07/2022
1	VaccinesIBA 12/2021
1	Antiviral Agents (Antivirals)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	OsteoprotegerinIBA 12/2020
1	Genetic Markers (Genetic Marker)IBA 12/2020
1	Lymphotoxin-alpha (Lymphotoxin)IBA 12/2020
1	Untranslated RNA (Noncoding RNA)IBA 08/2020
1	Protein Isoforms (Isoforms)IBA 08/2020
1	Caspase 3 (Caspase-3)IBA 12/2019
1	Tyrosine Kinase InhibitorsIBA 07/2018
1	bcr-abl Fusion ProteinsIBA 07/2018
1	daidzeinIBA 02/2018
1	16S Ribosomal RNAIBA 01/2018
1	Thiamine (Aneurin)FDA Link 01/2018
1	Ketone BodiesIBA 01/2018
1	Organophosphonates (Phosphonates)IBA 01/2018
1	DNA AdductsIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2018
1	Transfer RNA (tRNA)IBA 01/2018
1	Contraceptive Agents (Contraceptives)IBA 04/2017
1	Estrogens (Estrogen)FDA Link 04/2017
1	neem oilIBA 01/2017
1	Selective Estrogen Receptor Modulators (SERM)IBA 11/2016
1	Insulin (Novolin)FDA Link 07/2012
1	MitogensIBA 07/2012
1	LigandsIBA 07/2012
1	Bovine Serum AlbuminIBA 07/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	Hormones (Hormone)IBA 01/2012
1	ResveratrolIBA 01/2012
1	PolyphenolsIBA 01/2012

Therapy/Procedure

2	Therapeutics 12/2021 - 07/2021